Matthew C. Becker
YOU?
Author Swipe
View article: Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial
Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial Open
Background Vaccine immunogenicity is reduced in kidney transplant recipients (KTRs), especially in those using mycophenolate mofetil (MMF). Whether replacement of MMF by everolimus improves vaccine immunogenicity is unknown. Methods KTRs w…
View article: MP53-08 A QUALITATIVE ASSESSMENT OF DRIVERS, BARRIERS, AND VALUE IN ROBOTIC-ASSISTED LOWER URINARY TRACT RECONSTRUCTION
MP53-08 A QUALITATIVE ASSESSMENT OF DRIVERS, BARRIERS, AND VALUE IN ROBOTIC-ASSISTED LOWER URINARY TRACT RECONSTRUCTION Open
You have accessJournal of UrologyTrauma/Reconstruction/Diversion: Ureter (including Pyeloplasty) and Bladder Reconstruction (including fistula), Augmentation, Substitution, Diversion II (MP53)1 Sep 2021MP53-08 A QUALITATIVE ASSESSMENT OF D…
View article: SUN-074 Icodextrin- vs. Either Single or Dual Compartment Glucose-Based Solutions for Peritoneal Dialysis – A Systematic Review and Meta-Analysis
SUN-074 Icodextrin- vs. Either Single or Dual Compartment Glucose-Based Solutions for Peritoneal Dialysis – A Systematic Review and Meta-Analysis Open
Patients with end-stage renal disease (ESRD) undergoing peritoneal dialysis (PD) have options regarding the osmotic agents used in PD fluids (PDFs). These include hyper-osmolar glucose, as well as iso-osmolar icodextrin, a soluble glucose …